
样式: 排序: IF: - GO 导出 标记为已读
-
Farewell to Prof. Giovanni A. Fava after 30 Years and Welcome to the New Editors Psychother. Psychosom. (IF 25.617) Pub Date : 2022-07-05
Psychother Psychosom
-
The Effectiveness of 6 versus 12 Months of Dialectical Behavior Therapy for Borderline Personality Disorder: A Noninferiority Randomized Clinical Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2022-06-23 Shelley F. McMain, Alexander L. Chapman, Janice R. Kuo, Katherine L. Dixon-Gordon, Timothy Henry Guimond, Cathy Labrish, Wanrudee Isaranuwatchai, David L. Streiner
Introduction: Evidence-based psychotherapies for borderline personality disorder (BPD) are lengthy, posing a barrier to their access. Brief psychotherapy may achieve comparable outcomes to long-term psychotherapy for BPD. Evidence is needed regarding the comparative effectiveness of short- versus long-term psychotherapy for BPD. Objective: The aim was to determine if 6 months of Dialectical Behavior
-
An Editor’s Journey Ends, but the Journal’s Mission Continues Psychother. Psychosom. (IF 25.617) Pub Date : 2022-06-20 Giovanni A. Fava
Psychother Psychosom
-
Who’s Afraid of Benzodiazepines? Psychother. Psychosom. (IF 25.617) Pub Date : 2022-06-09 Richard Balon
Psychother Psychosom
-
Stigmatization of Benzodiazepines: Pharmacologic and Nonpharmacologic Contributions Psychother. Psychosom. (IF 25.617) Pub Date : 2022-06-09 Edward K. Silberman
Psychother Psychosom
-
Benzodiazepines Are Efficacious and Safe for Long-Term Use: Clinical Research Data and More than Sixty Years in the Market Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-31 Antonio E. Nardi, Laiana A. Quagliato
Psychother Psychosom
-
Efficacy of App-Based Cognitive Behavioral Therapy for Body Dysmorphic Disorder with Coach Support: Initial Randomized Controlled Clinical Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-19 Sabine Wilhelm, Hilary Weingarden, Jennifer L. Greenberg, Susanne S. Hoeppner, Ivar Snorrason, Emily E. Bernstein, Thomas H. McCoy, Oliver T. Harrison
Introduction: Body dysmorphic disorder (BDD) is severe, chronic, and undertreated. Apps could substantially improve treatment access. Objective: We provide an initial test of the usability and efficacy of coach-supported app-based cognitive behavioral therapy (CBT) for BDD. The Perspectives app covers core treatment components: psychoeducation, cognitive restructuring, exposure with response prevention
-
Evaluation of Inference-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder: A Multicenter Randomized Controlled Trial with Three Treatment Modalities Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-18
Introduction: Inference-based cognitive-behavioral therapy (I-CBT) is a specialized psychological treatment for obsessive-compulsive disorder (OCD) without deliberate and prolonged exposure and response prevention (ERP) that focuses on strengthening reality-based reasoning and correcting the dysfunctional reasoning giving rise to erroneous obsessional doubts and ideas. Objective: The present study
-
IFP News Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-17 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom
-
Representation of Benzodiazepines in Treatment Guidelines: The Paradox of Undesirable Objectivity Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-12 Vladan Starcevic
Psychother Psychosom
-
Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-11 Jiao Le, Lan Zhang, Weihua Zhao, Siyu Zhu, Chunmei Lan, Juan Kou, Qianqian Zhang, Yingying Zhang, Qin Li, Zhuo Chen, Meina Fu, Christian Montag, Rong Zhang, Wenxu Yang, Benjamin Becker, Keith M. Kendrick
Introduction: There are currently no approved drug interventions for social behavior dysfunction in autism spectrum disorder (ASD). Previous trials investigating effects of daily intranasal oxytocin treatment have reported inconsistent results and have not combined it with positive social interaction. However, in two preclinical studies we established that treatment every other day rather than daily
-
Diabetes Distress and Depression during COVID-19: Response to Breznoscakova et al. Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 Era Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-06 Andreas Schmitt, Bernhard Kulzer, Dominic Ehrmann, Thomas Haak, Norbert Hermanns
Psychother Psychosom
-
Erratum Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-05 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom
-
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-03 Steven L. Dubovsky, Dori Marshall
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory bodies as having limited benefit and significant risks. Data presented in this article support the use of these medications as treatments of choice for acute situational anxiety, chronic anxiety disorders, insomnia, alcohol withdrawal
-
Chronic Loneliness: Neurocognitive Mechanisms and Interventions Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-02
Psychother Psychosom
-
Chronic Loneliness: Neurocognitive Mechanisms and Interventions. Psychother. Psychosom. (IF 25.617) Pub Date : 2022-05-02 Mitjan Morr,Xiqin Liu,Rene Hurlemann,Benjamin Becker,Dirk Scheele
-
The Clinical Science of Euthymia: A Conceptual Map Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-14 Jenny Guidi, Giovanni A. Fava
Euthymia is a trans-diagnostic construct characterized by lack of mood disturbances; presence of positive affect; balance of psychological well-being dimensions, flexibility, consistency, and resistance to stress. The aim of this critical review is to draw a conceptual map of euthymia. Relationships with other constructs, continuum between euthymia and dysthymia with discomfort as an intermediate area
-
Talking about Side Effects in Psychotherapy Did Not Impair the Therapeutic Alliance in an Experimental Study Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-12
Psychother Psychosom
-
Talking about Side Effects in Psychotherapy Did Not Impair the Therapeutic Alliance in an Experimental Study Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-12 Beate Muschalla,Julia Müller,Anja Grocholewski,Michael Linden
-
Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 Era Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-07 Dagmar Breznoscakova, Maria Pallayova
Psychother Psychosom
-
Social Functioning in Individuals Affected by Childhood Maltreatment: Establishing a Research Agenda to Inform Interventions Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-05 Monique C. Pfaltz, Sarah L. Halligan, Shilat Haim-Nachum, Marie R. Sopp, Fredrik Åhs, Rahel Bachem, Eleonora Bartoli, Habte Belete, Tilahun Belete, Azi Berzengi, Daniel Dukes, Aziz Essadek, Naved Iqbal, Laura Jobson, Rachel Langevin, Einat Levy-Gigi, Antonia M. Lüönd, Chantal Martin-Soelch, Tanja Michael, Misari Oe, Miranda Olff, Deniz Ceylan, Vijaya Raghavan, Muniarajan Ramakrishnan, Vedat Sar, Georgina
Childhood maltreatment (CM) is linked to impairments in various domains of social functioning. Here, we argue that it is critical to identify factors that underlie impaired social functioning as well as processes that mediate the beneficial health effects of positive relationships in individuals exposed to CM. Key research recommendations are presented, focusing on: (1) identifying attachment-related
-
The Chronic Conditions Course: A Randomised Controlled Trial of an Internet-Delivered Transdiagnostic Psychological Intervention for People with Chronic Health Conditions Psychother. Psychosom. (IF 25.617) Pub Date : 2022-04-01 Blake F. Dear, Amelia J. Scott, Rhiannon Fogliati, Milena Gandy, Eyal Karin, Joanne Dudeney, Olav Nielssen, Sarah McDonald, Andreea I. Heriseanu, Madelyne A. Bisby, Louise Sharpe, Michael P. Jones, Shehzad Ali, Nickolai Titov
Introduction: Psychological adjustment to chronic health conditions is important, as poor adjustment predicts a range of adverse medical and psychosocial outcomes. Psychological treatments demonstrate efficacy for people with chronic health conditions, but existing research takes a disorder-specific approach and they are predominately delivered in face-to-face contexts. The internet and remotely delivered
-
When Withdrawal Symptoms Change the Meaning of Research Data Psychother. Psychosom. (IF 25.617) Pub Date : 2022-03-21 Fiammetta Cosci, Virginie-Anne Chouinard, Guy Chouinard
Psychother Psychosom
-
What Is a Review Article and What Are Its Purpose, Attributes, and Goal(s) Psychother. Psychosom. (IF 25.617) Pub Date : 2022-03-21 Richard Balon
Psychother Psychosom
-
Autoimmune Obsessive-Compulsive Disorder with Novel Anti-Basal Ganglia Antibodies Psychother. Psychosom. (IF 25.617) Pub Date : 2022-03-21 Dominique Endres, Lydia Mertens, Benjamin Berger, Marco Reisert, Kimon Runge, Kathrin Nickel, Katharina Domschke, Miriam A. Schiele, Horst Urbach, Nils Venhoff, Harald Prüss, Ludger Tebartz van Elst
Psychother Psychosom
-
Efficacy of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Results from the Multi-Center INTERACT Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2022-03-18 Inez Myin-Germeys, Evelyne van Aubel, Thomas Vaessen, Henrietta Steinhart, Annelie Klippel, Ginette Lafit, Wolfgang Viechtbauer, Tim Batink, Ruud van Winkel, Mark van der Gaag, Therese van Amelsvoort, Machteld Marcelis, Frederike Schirmbeck, Lieuwe de Haan, Ulrich Reininghaus
Introduction/Objective: This study aimed to investigate efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL), combining face-to-face therapy with an Ecological Momentary Intervention (EMI), in addition to treatment as usual (TAU) for psychotic distress, in comparison to TAU. Methods: Individuals aged 15–65 years with clinically established ultra-high risk or first episode of psychosis
-
Four-Week Mentalizing Imagery Therapy for Family Dementia Caregivers: A Randomized Controlled Trial with Neural Circuit Changes Psychother. Psychosom. (IF 25.617) Pub Date : 2022-03-14 Felipe A. Jain, Sergey V. Chernyak, Lisa D. Nickerson, Stefana Morgan, Rhiana Schafer, David Mischoulon, Richard Bernard-Negron, Maren Nyer, Cristina Cusin, Liliana Ramirez Gomez, Albert Yeung
Introduction: Family caregivers of patients with dementia suffer a high burden of depression and reduced positive emotions. Mentalizing imagery therapy (MIT) provides mindfulness and guided imagery skills training to improve balanced mentalizing and emotion regulation. Objective: Our aims were to test the hypotheses that MIT for family caregivers would reduce depression symptoms and improve positive
-
Comorbidity: From a Confounder in Longitudinal Clinical Research to the Main Issue in Population Management Psychother. Psychosom. (IF 25.617) Pub Date : 2022-02-23 Mary E. Charlson, Martin T. Wells
Psychother Psychosom
-
Intensity of Treatment as Usual and Its Impact on the Effects of Face-to-Face and Internet-Based Psychotherapy for Depression: A Preregistered Meta-Analysis of Randomized Controlled Trials Psychother. Psychosom. (IF 25.617) Pub Date : 2022-02-14 Thomas Munder, Alessia Geisshüsler, Tobias Krieger, Johannes Zimmermann, Markus Wolf, Thomas Berger, Birgit Watzke
Introduction: Treatment as usual (TAU) is the most frequently used control group in randomized trials of psychotherapy for depression. Concerns have been raised that the heterogeneity of treatments in TAU leads to biased estimates of psychotherapy efficacy and to an unclear difference between TAU and control groups like waiting list (WL). Objective: We investigated the impact of control group intensity
-
The Role of Psychological Interventions in the Maintenance Treatment of Depression Psychother. Psychosom. (IF 25.617) Pub Date : 2022-02-14 Elisabeth Schramm, Moritz Elsaesser, Jenny Guidi
Psychother Psychosom
-
The Medication Appropriateness Index: A Clinimetric Measure Psychother. Psychosom. (IF 25.617) Pub Date : 2022-02-14 Joseph T. Hanlon, Kenneth E. Schmader
Psychother Psychosom
-
Biosocial Pathogenesis Psychother. Psychosom. (IF 25.617) Pub Date : 2022-02-01 Ralph I. Horwitz, Burton H. Singer, Allison Hayes-Conroy, Mark R. Cullen, McKayla Mawn, Katharine Colella, Ida Sim
Psychother Psychosom
-
Anxiolytic Effects of Chronic Intranasal Oxytocin on Neural Responses to Threat Are Dose-Frequency Dependent Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-27 Juan Kou, Yingying Zhang, Feng Zhou, Zhao Gao, Shuxia Yao, Weihua Zhao, Hong Li, Yi Lei, Shan Gao, Keith M. Kendrick, Benjamin Becker
Introduction: Anxiety disorders are prevalent mental conditions characterized by exaggerated anxious arousal and threat reactivity. Animal and human studies suggest an anxiolytic potential of the neuropeptide oxytocin (OT), yet, while a clinical application will require chronic administration protocols, previous human studies have exclusively focused on single-dose (acute) intranasal OT effects. Objective:
-
A Randomized Clinical Trial of Attempted Suicide Short Intervention Program versus Crisis Counseling in Preventing Repeat Suicide Attempts: A Two-Year Follow-Up Study Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-20 Petri Arvilommi, Jukka Valkonen, Lars H. LIndholm, Selma Gaily-Luoma, Kirsi Suominen, Outi M. Ruishalme, Marena Kukkonen, Harri Sihvola, Erkki Isometsä
Introduction: The Attempted Suicide Short Intervention Program (ASSIP) is a brief psychotherapeutic intervention, and a pivotal study found it to be remarkably effective in reducing repeat suicide attempts. Objective: To compare the effectiveness of ASSIP to crisis counseling (CC) in a randomized clinical trial (ISRCTN13464512). Methods: Adult patients receiving treatment for a suicide attempt in a
-
Effectiveness of an Internet-Based Self-Help Intervention versus Public Mental Health Advice to Reduce Worry during the COVID-19 Pandemic: A Pragmatic, Parallel-Group, Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-20 Hanna Heckendorf, Dirk Lehr, Leif Boß
Introduction: The mental health burden for the general population due to the COVID-19 pandemic has been highlighted. Evidence on effective, easily accessible public health interventions to reduce worry, a major transdiagnostic risk-factor for, e.g., anxiety and depression, is scarce. Objective: In a pragmatic randomized controlled trial, we aimed to assess whether an internet cognitive-behavioral self-help
-
Effectiveness of Individual Cognitive-Behavioral Therapy and Predictors of Outcome in Adult Patients with Obsessive-Compulsive Disorder Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-14 Norbert Kathmann, Tanja Jacobi, Björn Elsner, Benedikt Reuter
Introduction: Cognitive-behavioral therapy (CBT) for obsessive-compulsive disorder (OCD) has proven its efficacy in randomized controlled trials (RCTs). Objective: To test generalizability to routine care settings, we conducted an effectiveness study to provide naturalistic outcome data and their predictors. Methods: Pre-post changes in symptoms and impairment as well as response rates were determined
-
Charlson Comorbidity Index: A Critical Review of Clinimetric Properties Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-06 Mary E. Charlson, Danilo Carrozzino, Jenny Guidi, Chiara Patierno
The present critical review was conducted to evaluate the clinimetric properties of the Charlson Comorbidity Index (CCI), an assessment tool designed specifically to predict long-term mortality, with regard to its reliability, concurrent validity, sensitivity, incremental and predictive validity. The original version of the CCI has been adapted for use with different sources of data, ICD-9 and ICD-10
-
Comment on Schäfer et al. “Impact of COVID-19 on Public Mental Health and the Buffering Effect of a Sense of Coherence”: High Level of COVID-19-Related Posttraumatic Stress in COVID-19 Survivors with Low Sense of Coherence Psychother. Psychosom. (IF 25.617) Pub Date : 2022-01-05 Hannah Dinse, Leoni-Johanna Speichert, Adam Schweda, Oliver Witzke, Margarethe Konik, Markus Zettler, Hana Rohn, Mark Stettner, Venja Musche, Benjamin Weismüller, Klaas Herchert, Madeleine Fink, Sheila Moradian, Martin Teufel, Eva-Maria Skoda, Alexander Bäuerle
Psychother Psychosom
-
Dose-Response Relationship in Selective Serotonin and Norepinephrine Reuptake Inhibitors in the Treatment of Major Depressive Disorder: A Meta-Analysis and Network Meta-Analysis of Randomized Controlled Trials Psychother. Psychosom. (IF 25.617) Pub Date : 2021-12-29 Lena Rink, Anne Adams, Cora Braun, Tom Bschor, Kathrin Kuhr, Christopher Baethge
Introduction: Selective serotonin and norepinephrine reuptake inhibitors (SNRI) are among the most prescribed antidepressants, and dose escalation is a frequently applied strategy after non-response to an initially prescribed dose. Objective: This meta-analysis aimed to find evidence of a dose-response relationship or to the contrary in direct comparisons of different SNRI doses in patients with major
-
Loneliness and Major Depressive Disorder in the Elderly with a History of Suicidal Ideation or Attempt: A Comment on “Therapist-Guided Internet-Based Treatments for Loneliness” by Käll et al. Psychother. Psychosom. (IF 25.617) Pub Date : 2021-12-14 Hiu Ching Siu, Shwu-Hua Lee, Josephine Sheron Au, Alfred Pak-Kwan Lo, Chih-Mao Huang, Yun-Fang Tsai, Tatia Mei-Chun Lee, Ho-Ling Liu, Chemin Lin, Chui-De Chiu
Psychother Psychosom
-
Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study) Psychother. Psychosom. (IF 25.617) Pub Date : 2021-12-07 Andreas Schmitt, Bernhard Kulzer, André Reimer, Christian Herder, Michael Roden, Thomas Haak, Norbert Hermanns
Introduction: Depression is a common and serious complication of diabetes. Treatment approaches addressing the specific demands of affected patients are scarce. Objective: The aim of this work was to test whether a stepped care approach for patients with diabetes and depression and/or diabetes distress yields greater depression reduction than treatment-as-usual. Methods: Two-hundred and sixty patients
-
Effectiveness of a Videoconferencing-Delivered Psychological Intervention for Mental Health Problems during COVID-19: A Proof-of-Concept Randomized Clinical Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-12-07 Richard A. Bryant, Katie S. Dawson, Dharani Keyan, Suzanna Azevedo, Srishti Yadav, Jenny Tran, Natasha Rawson, Samuel Harvey
Introduction: Anxiety and depression have increased markedly during the COVID-19 pandemic. There is a lack of evidence-based strategies to address these mental health needs during the pandemic. Objective: We aim to conduct a proof-of-concept trial of the efficacy of a brief group-based psychological intervention delivered via videoconferencing for adults in Australia distressed by the pandemic. Methods:
-
Treating Insomnia with High Risk of Depression Using Therapist-Guided Digital Cognitive, Behavioral, and Circadian Rhythm Support Interventions to Prevent Worsening of Depressive Symptoms: A Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-12-06 Jeanne Leerssen, Oti Lakbila-Kamal, Laura M.S. Dekkers, Savannah L.C. Ikelaar, Anne C.W. Albers, Tessa F. Blanken, Jaap Lancee, Glenn J.M. van der Lande, Teodora Maksimovic, Sophie E. Mastenbroek, Joyce E. Reesen, Sjors van de Ven, Tanja van der Zweerde, Jessica C. Foster-Dingley, Eus J.W. Van Someren
Introduction: The global disease burden of major depressive disorder urgently requires prevention in high-risk individuals, such as recently discovered insomnia subtypes. Previous studies targeting insomnia with fully automated eHealth interventions to prevent depression are inconclusive: dropout was high and likely biased, and depressive symptoms in untreated participants on average improved rather
-
Forty Years of Clinimetrics Psychother. Psychosom. (IF 25.617) Pub Date : 2021-11-26 Giovanni A. Fava
Psychother Psychosom
-
Psychosocial Factors Predict COVID-19 Vaccine Side Effects Psychother. Psychosom. (IF 25.617) Pub Date : 2021-11-04 Andrew L. Geers, Kelly S. Clemens, Kate Faasse, Ben Colagiuri, Rebecca Webster, Lene Vase, Mette Sieg, Emily Jason, Luana Colloca
Psychother Psychosom
-
Contents Vol. 90, 2021 Psychother. Psychosom. (IF 25.617) Pub Date : 2021-10-11
Psychother Psychosom 2021;90:I–VI
-
Enhancing Cognitive Restructuring with Concurrent Repetitive Transcranial Magnetic Stimulation: A Transdiagnostic Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-09-22 Andrada D. Neacsiu, Lysianne Beynel, John P. Powers, Steven T. Szabo, Lawrence G. Appelbaum, Sarah H. Lisanby, Kevin S. LaBar
Introduction: Emotional dysregulation constitutes a serious public health problem in need of novel transdiagnostic treatments. Objective: To this aim, we developed and tested a one-time intervention that integrates behavioral skills training with concurrent repetitive transcranial magnetic stimulation (rTMS). Methods: Forty-six adults who met criteria for at least one DSM-5 disorder and self-reported
-
Comment on Evers et al. “What Should Clinicians Tell Patients about Placebo and Nocebo Effects?”: Open-Label Placebos May Reduce Feelings of Hunger during Weight Loss Psychother. Psychosom. (IF 25.617) Pub Date : 2021-08-25 Michael Schaefer, Anja Kühnel, Sören Enge
Psychother Psychosom
-
Effectiveness of Self-Help Plus in Preventing Mental Disorders in Refugees and Asylum Seekers in Western Europe: A Multinational Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-20 Marianna Purgato, Kenneth Carswell, Federico Tedeschi, Ceren Acarturk, Minna Anttila, Teresa Au, Malek Bajbouj, Josef Baumgartner, Massimo Biondi, Rachel Churchill, Pim Cuijpers, Markus Koesters, Chiara Gastaldon, Zeynep Ilkkursun, Tella Lantta, Michela Nosè, Giovanni Ostuzzi, Davide Papola, Mariana Popa, Valentina Roselli, Marit Sijbrandij, Lorenzo Tarsitani, Giulia Turrini, Maritta Välimäki, Lauren
Introduction: Self-Help Plus (SH+) is a group-based psychological intervention developed by the World Health Organization for managing stress. Objective: To assess the effectiveness of SH+ in preventing mental disorders in refugees and asylum seekers in Western Europe. Methods: We conducted a randomized controlled trial in 5 European countries. Refugees and asylum seekers with psychological distress
-
Prodromal Symptoms in Depression: A Systematic Review Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-20 Giada Benasi, Giovanni A. Fava, Jenny Guidi
Introduction: Appraisal of prodromal symptoms of unipolar depression may complement the traditional cross-sectional approach and provide a longitudinal perspective, according to a staging model of the illness. Objective: To provide an updated systematic review of clinical studies concerned with prodromal symptoms of unipolar depression, according to PRISMA guidelines. Methods: Keyword searches were
-
A Randomized Clinical Trial of Cognitive-Behavioral Therapy for Insomnia to Augment Posttraumatic Stress Disorder Treatment in Survivors of Interpersonal Violence Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-15 Wilfred R. Pigeon, Hugh F. Crean, Catherine Cerulli, Autumn M. Gallegos, Todd M. Bishop, Kathi L. Heffner
Introduction: Individuals exposed to interpersonal violence (IPV) commonly develop posttraumatic stress disorder (PTSD) with co-occurring depression and insomnia. Standard PTSD interventions such as cognitive processing therapy (CPT) do not typically lead to remission or improved insomnia. Cognitive behavioral therapy for insomnia (CBTi) improves insomnia in individuals with PTSD, but PTSD severity
-
Keeping Up with the Psychiatric Literature: A Survival Guide Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-12 Joel Yager, Steven L. Dubovsky, Peter P. Roy-Byrne
Psychother Psychosom
-
More (Adjustment) Is Not Always Better: How Directed Acyclic Graphs Can Help Researchers Decide Which Covariates to Include in Models for the Causal Relationship between an Exposure and an Outcome in Observational Research Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-12 Elizabeth W. Diemer, James I. Hudson, Kristin N. Javaras
Psychother Psychosom
-
Erratum Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-09 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom
-
Alternative Diagnostic Models of the Psychotic Disorders: Evidence-Based Choices Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-07 Bruce M. Cohen, Dost Öngür, Suzann M. Babb
Standard diagnostic systems, the predominantly categorical DSM-5 and ICD-11, have limitations in validity, utility, and predictive and descriptive power. For psychotic disorders, these issues were partly addressed in current versions, but additional modifications are thought to be needed. Changes should be evidence based. We reviewed categorical, modified-categorical, and continuum-based models versus
-
When Anxiety and Depression Coexist: The Role of Differential Diagnosis Using Clinimetric Criteria Psychother. Psychosom. (IF 25.617) Pub Date : 2021-07-01 Fiammetta Cosci, Giovanni A. Fava
Depressive and anxiety disorders are frequently associated. Depression may be a complication of anxiety and anxiety can complicate depression. The nature of their relationship has been a source of controversy. Reviews generally base their conclusions on randomized controlled trials and meta-analyses that refer to the average patient and often clash with the variety of clinical presentations that may
-
Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-06-29 Samuel T. Wilkinson, Taeho Greg Rhee, Jutta Joormann, Ryan Webler, Mayra Ortiz Lopez, Brandon Kitay, Madonna Fasula, Christina Elder, Lisa Fenton, Gerard Sanacora
Introduction: Ketamine has emerged as a rapid-acting antidepressant. While ongoing treatment can prevent relapse, concerns exist regarding long-term exposure. Objective: We conducted a randomized trial to examine the feasibility and efficacy of cognitive behavioral therapy (CBT) following intravenous ketamine in treatment-resistant depression (TRD). Methods: Subjects with TRD were recruited and treated
-
Therapist-Guided Internet-Based Treatments for Loneliness: A Randomized Controlled Three-Arm Trial Comparing Cognitive Behavioral Therapy and Interpersonal Psychotherapy Psychother. Psychosom. (IF 25.617) Pub Date : 2021-06-28 Anton Käll, Malin Bäck, Camilla Welin, Hanna Åman, Rasmus Bjerkander, Matilda Wänman, Tomas Lindegaard, Matilda Berg, Hajdi Moche, Roz Shafran, Gerhard Andersson
Introduction: Chronic loneliness has been linked to many adverse outcomes, including mental health problems. Psychological treatment of loneliness can be effective, but the evidence base is limited. Objective: To investigate the efficacy of 2 internet-based interventions based on cognitive behavioral therapy (ICBT) and interpersonal psychotherapy (IIPT) relative to a wait-list control group and each
-
Transdiagnostic versus Diagnosis-Specific Group Cognitive Behavioral Therapy for Anxiety Disorders and Depression: A Randomized Controlled Trial Psychother. Psychosom. (IF 25.617) Pub Date : 2021-06-10 Nina Reinholt, Morten Hvenegaard, Anne Bryde Christensen, Anita Eskildsen, Carsten Hjorthøj, Stig Poulsen, Mikkel Berg Arendt, Nicole Kristjansen Rosenberg, Jasmin Rejaye Gryesten, Ruth Nielsen Aharoni, Anja Johnsen Alrø, Clas Winding Christensen, Sidse Marie Arnfred
Introduction: The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) delivered in a group format could facilitate the implementation of evidence-based psychological treatments. Objective: This study compared the efficacy of group UP and diagnosis-specific cognitive behavioral therapy (dCBT) for anxiety and depression in outpatient mental health services. Methods: In this pragmatic
-
IFP News Psychother. Psychosom. (IF 25.617) Pub Date : 2021-06-08 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom